National Inferior Vena Cava (IVC) Filter Registry

NCT ID: NCT01367184

Last Updated: 2013-06-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

20000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-05-31

Study Completion Date

2014-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Inferior vena cava (IVC) filter is an important therapeutic device used in the management of venous thrombo-embolism (VTE) in patients that are contra-indicated for anti-coagulation therapy. While there has been significant increase in the use of filters , unfortunately there are no standardized collection of data to track, compare outcomes, report safety and efficacy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The registry is a multi-institutional bioinformatics database for the collection of data relevant to Inferior vena cava filters. Participating study centers may enroll patients and enter data in the web-based registry that include demographics, clinical features, management details and follow-up up to 48 months.

The purpose of this study is to improve our understanding of the retrieval rate, long term safety and efficacy on IVC filters placed in North America.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Venous Thrombo-embolism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Data obtained in line with good clinical practice,applicable laws and regulation
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

American Venous Forum

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Brajesh K Lal

Role: STUDY_CHAIR

University of Maryland Medical Center,Baltimore

John E. Rectenwald

Role: PRINCIPAL_INVESTIGATOR

University of Michigan

Uchenna N Onyeachom

Role: STUDY_DIRECTOR

American Venous Forum

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Exempla Lutheran Medical Center

Denver, Colorado, United States

Site Status

University of Florida , Division of Vascular Surgery & Endovascular Therapy

Gainesville, Florida, United States

Site Status

Bayfront Medical Center

St. Petersburg, Florida, United States

Site Status

Medical Center of Central Georgia

Macon, Georgia, United States

Site Status

Eastern Idaho Regional Medical Center

Idaho Falls, Idaho, United States

Site Status

University of Chicago Hospitals

Chicago, Illinois, United States

Site Status

Southern Illinois University School of Medicine

Springfield, Illinois, United States

Site Status

University Of Kentucky , Vascular and Endovascular Divison

Lexington, Kentucky, United States

Site Status

Tuoro Infirmary

New Orleans, Louisiana, United States

Site Status

University Of Michigan Health System

Ann Arbor, Michigan, United States

Site Status

St. Luke's Medical Center

Chesterfield, Missouri, United States

Site Status

St Peters Hospital

Helena, Montana, United States

Site Status

Brooklyn Hospital

New York, New York, United States

Site Status

University Of Rochester Medical Center

Rochester, New York, United States

Site Status

Stony Brook University Medical Center, Vein Clinic

Stony Brook, New York, United States

Site Status

Good Samaritan Hospital

Cincinnati, Ohio, United States

Site Status

Jobst Vascular Institute

Toledo, Ohio, United States

Site Status

Doylestown Hospital

Doylestown, Pennsylvania, United States

Site Status

Lancaster General Hospital

Lancaster, Pennsylvania, United States

Site Status

University of Pittsburgh School of Medicine Division of Vascular Surgery

Pittsburgh, Pennsylvania, United States

Site Status

Palmetto Health and Providence Hospital

Columbia, South Carolina, United States

Site Status

Vascular Health Alliance, Greenville Hospital System

Greenville, South Carolina, United States

Site Status

Avera Sacred Heart Hospital

Yankton, South Dakota, United States

Site Status

Northwest Texas Hospital

Amarillo, Texas, United States

Site Status

University of Texas Medical Branch

Galveston, Texas, United States

Site Status

Intermountain Medical Center

Murray, Utah, United States

Site Status

West Virginia University Healthcare

Morgantown, West Virginia, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AVR-IVC-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.